(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Bob Mulroy, CEO of Merrimack Pharmaceuticals, on biotech earnings, consumer health and oncology, and its product pipeline. Broadcasting live from the Boston Convention and Exhibition Center.

Chewy Shares Slump as Executives Say Consumers Remain Pressured
16:06

GE to Buy Consolidated Precision Products for $11.75 Billion
22:06

Introducing: Bloomberg Money
00:30